---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013213"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:47:09.356141+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals grants 500k shares and 2M options to CEO; CFO and directors each receive 100k shares

## Summary
- CEO Jacob Cohen receives 500,000 common shares as 2025 bonus and options to purchase 2,000,000 shares at $2.30.
- Options vest over 18 months (500k per milestone); full acceleration on change of control or termination without cause.
- CFO Eugene Johnston and directors Myers, Hamilton, D'Alessio each receive 100,000 fully vested common shares as 2025 bonuses.

## SEC filing metadata
- accession: 0001493152-25-013213
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225013213/0001493152-25-013213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225013213/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013213
- JSON: https://secwatch.observer/filing/0001493152-25-013213.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013213.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.